| Trial registration number
|
IRCT20200408046990N12 |
Full text link
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/66470
|
First author
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Majid Ghayour-mobarhan
|
Contact
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
ghayourm@mums.ac.ir
|
Registration date
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-11-15
|
Recruitment status
Last imported at : Oct. 25, 2023, 4:13 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
multi-center
|
Study aim
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Clinical or laboratory diagnosis of mild to moderate COVID-19
Age between 18-85 y
Sign of written consent
|
Exclusion criteria
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Pregnancy and lactation
History of allergy to melatonin
Immunosuppression history
Lactase deficiency
Concomitant use of alcohol and 1A2 inhibitors
|
Number of arms
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mashhad University of Medical Sciences
|
Inclusion age min
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
85
|
Countries
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
40
|
primary outcome
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Fever
Clinical response to the treatment (including improvement of cough, myalgia, headache, olfactory and taste disorders)
Radiologic improvement
Laboratory response
Drug adverse reaction
|
Notes
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Nov. 21, 2022, 2:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 779, "treatment_name": "Melatonin", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|